CHARACTERIZATION OF HUMAN TYPE-II PROCOLLAGEN AND COLLAGEN-SPECIFIC ANTIBODIES AND THEIR APPLICATION TO THE STUDY OF HUMAN TYPE-II COLLAGENPROCESSING AND ULTRASTRUCTURE
Sa. Jimenez et al., CHARACTERIZATION OF HUMAN TYPE-II PROCOLLAGEN AND COLLAGEN-SPECIFIC ANTIBODIES AND THEIR APPLICATION TO THE STUDY OF HUMAN TYPE-II COLLAGENPROCESSING AND ULTRASTRUCTURE, Matrix biology, 16(1), 1997, pp. 29-39
Type II collagen is the most abundant collagen in articular cartilage
and, together with other tissue-specific collagens and proteoglycans,
provides the tissue with its shock-absorbing properties and its resili
ency to stress. Specific antibodies which recognize various collagen t
ypes have been very useful in the study of collagen biosynthesis, stru
cture and metabolism in normal and pathological conditions. Antibodies
which recognize epitopes of type II collagen have been described prev
iously; however, many of these antibodies display cross-reactivity wit
h other collagens or with type II collagen from other species, reflect
ing the high degree of homology of the helical domains of fibrillar co
llagens. In this study, we prepared antibodies to sequential determina
nts of human type II procollagen employing synthetic peptides with seq
uences deduced from the nucleotide sequence of the human alpha 1(II) p
rocollagen cDNA. The antibodies were highly specific for epitopes in e
ither the C-terminal propeptide or the telopeptide of the human type I
I collagen and did not cross-react with other human interstitial colla
gens or with murine type II collagen. These antibodies were used in co
njunction with biosynthetic labeling to study the secretion and proces
sing of human type II procollagen and collagen in human chondrocytes i
n vitro. The results indicated that a lag period of about 90 min was r
equired for the secretion of newly synthesized type II procollagen. Co
nversion of the secreted procollagen into fully processed alpha-chains
and their deposition in the cell layer were first apparent 240 min fo
llowing the intitiation of biosynthetic labeling. The antibodies were
also used to examine, by immunoelectron microscopy, the structure of t
he extracellular matrix produced by human chondrocytes maintained in l
ong-term cultures under conditions which permit the preservation of th
e cartilage-specific phenotype. These highly specific antibodies provi
de valuable tools to study the metabolism and structure of human type
II procollagen and collagen in normal and pathologic conditions.